IDStewardship

DECEMBER 12, 2023

In this article a clinical pharmacist discusses ways that preceptors may integrate generative artificial intelligence programs into pharmacy education for student and resident learning experiences. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Generative artificial intelligence was NOT used to create this text. Although, maybe it would be better if I had used it!

Communication 305

Communication Patient Care 305

Drug Topics

DECEMBER 12, 2023

The approvals mark a turning point in the ongoing effort to manage sickle cell disease, the most common inherited red blood cell disorder in the United States.

FDA 201

FDA 201

STAT

DECEMBER 12, 2023

Medicare Advantage beneficiaries on Tuesday filed a class-action lawsuit alleging that the health insurance giant Humana illegally used an algorithm to prematurely cut off payment for rehabilitation care after patients suffered serious illnesses and injuries. The suit, filed in U.S. District Court in Western Kentucky, argues Humana’s reliance on the algorithm, known as nH Predict, was part of a fraudulent scheme to reap a windfall by systematically denying claims to desperately ill people

Insurance 145

Insurance 145

Pharmacy Times

DECEMBER 12, 2023

An FDA approval of 3,4-Methylenedioxy-methamphetamine (MDMA)–assisted therapy would require the Drug Enforcement Administration to reschedule MDMA in acknowledgement of its medical use, making it available for prescription medical use.

FDA 145

FDA 145

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

STAT

DECEMBER 12, 2023

In the months after his father died of complications from pancreatic cancer, Reed Jobs found it difficult to go back to life as it was before. He was a sophomore studying biology at Stanford University and, up until October 2011, had always planned to pursue a career in cancer research. His father had been diagnosed when he was a preteen and he had spent much of his adolescence thinking about treatments and clinical trials, like many people whose parents are diagnosed with the disease during the

144

144

Fierce Pharma

DECEMBER 12, 2023

Over the past several years, drug shortages have vexed doctors and patients on both sides of the Atlantic, prompting lawmakers and government agencies to take action in both Europe and the U.S. | Tuesday, the European Medicines Agency laid out a list of more than 300 critical generic drugs that could fall prey to future shortages. Inclusion in the list doesn’t mean a particular drug is likely to experience a shortage anytime soon, the EMA said.

133

133

Pharmacy Times

DECEMBER 12, 2023

Biologics for plaque psoriasis has been associated with an atopic dermatitis phenotype, paradoxical eczema, but the risk factors are not well known.

132

132

STAT

DECEMBER 12, 2023

BOSTON — Chongcan Zhu, an 83-year-old longtime resident of Boston, lives alone — but she doesn’t feel a sense of isolation when it comes to receiving health care. That’s thanks to the van that comes straight to the senior residential community where she lives, providing services to people dealing with conditions like high blood pressure and cholesterol, diabetes, and substance use disorders.

Hospitals 144

Hospitals 144

Pharmacy Times

DECEMBER 12, 2023

The study authors note that low skin cancer screening (SCS) participation, the participants’ better health than nonparticipants, and examination biases may be contributing factors to the insignificant results.

132

132

STAT

DECEMBER 12, 2023

After decades of limited progress in the treatment of sickle cell disease (SCD), both patients and physicians are on the verge of monumental change. On Friday, the Food and Drug Administration approved Vertex/CRISPR Therapeutics’ Casgevy and Bluebird Bio’s Lyfgenia, the first one-time gene therapies that will treat the underlying cause of SCD rather than just the symptoms.

FDA 142

FDA 142

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

DECEMBER 12, 2023

Massachusetts healthcare organizations announced this week that every hospital, health system and local health plan in the state is removing “stigmatizing or invasive” mental health questions from | In a nationwide first, every hospital, health system and local health plan in the state has signed on to removing sensitive mental health questions from physician credentialing processes that advocates say inhibit their ability to seek help.

Hospitals 128

Hospitals 128

STAT

DECEMBER 12, 2023

In 2011, the Centers for Medicare and Medicaid Services created the annual wellness visit (AWV), a new visit type with no cost to Medicare patients, better reimbursement to primary care practices, and higher assigned credit for clinicians’ work. The visit takes about 30 minutes and includes a questionnaire covering home safety, falls risk, and ability to perform activities of daily living, along with a survey of recommended preventive services and depression and dementia screening.

Insurance 128

Insurance 128

Fierce Healthcare

DECEMBER 12, 2023

Practice Better, an all-in-one practice management software platform, has launched its take on an artificial intelligence charting assistant. | The AI tool is intended to give practitioners back critical face time with patients and securely records, transcribes and summarizes client sessions in a practitioner’s charting workflow.

126

126

STAT

DECEMBER 12, 2023

When Sanofi terminated its partnership with Maze Therapeutics this week to develop an experimental drug for Pompe disease, Maze CEO Jason Coloma did not learn the news in a conference call with the French pharma giant or even an email. He found out when Sanofi issued a public statement. Responding to the U.S. Federal Trade Commission’s move to block the licensing deal, Sanofi said it disagreed with the agency’s action, but determined that fighting it in court was “not in the

128

128

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

European Pharmaceutical Review

DECEMBER 12, 2023

Yannis Morel, Executive Vice President of product portfolio strategy and business development of Innate Pharma SA, offers insight on engineering antibodies to develop antibody-based NK cell therapeutics. He discusses why NK cell therapy’s ability to generate ‘synthetic immunity’ in the body means this modality holds potential as an anti-cancer treatment.

Immunization 124

Immunization Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 124

STAT

DECEMBER 12, 2023

SAN DIEGO — The sickle cell community has for the past few days been buzzing with news of the first-ever approved gene therapies for the devastating disease. Meanwhile, researchers at the American Society of Hematology meeting on Tuesday are reporting advances in a less expensive and more established strategy proven to cure patients: bone marrow transplant.

Chemotherapy 127

Chemotherapy Immunization 127

Pharmacy Times

DECEMBER 12, 2023

However, a survival benefit was observed with using a signaling inhibitor in general for patients with angioimmunoblastic T-cell lymphoma.

123

123

Drug Topics

DECEMBER 12, 2023

A Q&A with Robert Walker, MD, senior vice president and chief medical officer at Novavax.

Vaccines 123

Vaccines 123

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

DECEMBER 12, 2023

In a recent study, people who lived in disadvantaged or rural areas were just as likely to receive the second-generation medications as people in urban areas.

122

122

Drug Topics

DECEMBER 12, 2023

A recent study found that cannabis exposure over the course a pregnancy was associated with small-for-gestational-age birth, medically indicated preterm birth, stillbirth, or hypertensive disorders of pregnancy.

123

123

Fierce Healthcare

DECEMBER 12, 2023

Seven years in the making, a nationwide network to exchange patient data called the Trusted Exchange Framework and Common Agreement is now operational, marking a critical step in establishing unive | Seven years in the making, a nationwide network to exchange patient data called the Trusted Exchange Framework and Common Agreement is now operational, marking a critical step in establishing universal connectivity across providers.

122

122

Pharmacy Times

DECEMBER 12, 2023

These data support the combination of daratumumab plus VRd followed by daratumumab and lenalidomide maintenance as a new standard of care for transplant-eligible patients.

121

121

Fierce Healthcare

DECEMBER 12, 2023

Healthcare leadership may be more optimistic going into 2024 than the year prior, but more than three in five say they're hoping for greener pastures within the next 12 months, according to a new s | A new poll of provider organization leadership found that 62% are planning a job change within the next 12 months. Nearly four in five say they've been propositioned within the past six months.

119

119

STAT

DECEMBER 12, 2023

SAN DIEGO — One of the toughest subtypes of acute leukemia involves a genetic alteration in the KMT2A gene. Many cancers with this genetic alteration end up relapsing or don’t respond to treatment, but new data presented at the annual American Society of Hematology meeting offer hope of a new targeted therapy for these patients. The study, called the Phase 2 Augment-101 trial, tested Syndax’s revumenib in patients with relapsed or refractory leukemia with these KMT2A genetic

117

117

Fierce Healthcare

DECEMBER 12, 2023

Optum Rx is launching a new weight management program aimed at improving outcomes and addressing affordability. | Optum Rx is launching a new weight management program aimed at improving outcomes and addressing affordability.

117

117

pharmaphorum

DECEMBER 12, 2023

Coaching and Medical Affairs: The View from the Frontline Mike.

115

115

STAT

DECEMBER 12, 2023

SAN DIEGO — Johnson & Johnson’s multiple myeloma therapy, Darzalex, is already a blockbuster. Now results from a late-stage trial announced Tuesday during this year’s meeting of the American Society of Hematology offer evidence to support broader use of the drug. In the Phase 3 trial, known as Perseus, newly diagnosed patients about to receive an infusion of their own blood stem cells were randomly assigned a standard three-drug treatment or the same cocktail with the ad

Immunization 115

Immunization 115

pharmaphorum

DECEMBER 12, 2023

Can China’s biotech industry weather frosty US relations? Mike.

115

115

Fierce Pharma

DECEMBER 12, 2023

To complete its acquisition of Seagen, what did Pfizer need to do to satisfy antitrust concerns of the Federal Trade Commission? | By agreeing to donate royalties on its U.S. sales of bladder cancer drug Bavencio, Pfizer has received the go-ahead to finalize its $43 billion buyout of Seagen, the company said on Tuesday. Pfizer expects to close the merger on Thursday.

114

114

pharmaphorum

DECEMBER 12, 2023

Is the future of pharmaceutical drugs in the delivery? Mike.

111

111

Drug Store News

DECEMBER 12, 2023

NACDS and NCPA praised the passage of the Lower Costs, More Transparency Act by the U.S. House of Representatives, which is a vital aspect of PBM reform.

110

110

pharmaphorum

DECEMBER 12, 2023

BMS bolts on SystImmune bispecific ADC in $8.4bn deal Phil.

111

111

Fierce Healthcare

DECEMBER 12, 2023

On the heels of price transparency legislation gaining momentum in Congress, software platform Turquoise Health today revealed data showing health costs did not grow faster than the rate of inflati | Healthcare costs, perhaps surprisingly, have not exceeded the rate of inflation. But the payer reimbursement rate to providers for certain services can still vary greatly, price transparency data shows.

109

109